Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01815294
Title A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult
Covered Countries USA | GBR | ESP | BEL

Facility Status City State Zip Country Details
Nashville Tennessee United States Details
San Antonio Texas United States Details
Brussel Belgium Details
Wilrijk Belgium Details
Barcelona Spain Details
Madrid Spain Details
Valencia Spain Details
London United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field